Tablets & Capsules

TC0416

Issue link: https://www.e-digitaleditions.com/i/666166

Contents of this Issue

Navigation

Page 65 of 71

54 April 2016 Tablets & Capsules Flow of Solids in Bins, Hoppers, Chutes, and Feeders. June 7-8 in San Francisco, CA. Conducted by the American Institute of Chemical Engi- neers. Tel. 800 242 4363. Website: www.aiche.org. Scale-up: Transferring Products to Pro- duction. June 7-9 in Schopfheim, Ger- many. Conducted by Bosch Packaging Technology. Tel. +49 7622 6884 121. Website: www.boschpackaging.com. Tablet Compression. June 9 in Boston, MA. Conducted by Techceuticals. Tel. 216 658 8038. Website: www.techceu- ticals.com. Pneumatic Conveying of Bulk Solids. June 9 in San Francisco, CA. Con- ducted by the American Institute of Chemical Engineers. Tel. 800 242 4363. Website: www.aiche.org. American Drug Delivery and Formu- lation Summit. June 13-14 in San Diego, CA. Conducted by Industry Dynamics. Tel. +44 20 8269 7110. Website: www.ddfsummit.com. Basics of Tablet Manufacturing and Troubleshooting. June 14-16 in Saint Charles, MO. Conducted by Natoli. Tel. 636 926 8900. Website: www.natoli.com. CPhI China. June 21-23 in Shanghai, China. Conducted by UBM. Tel. +31 20 40 99 544. Website: www.cphi.com. Interphex Japan. June 29-July 1 in Tokyo, Japan. Conducted by Reed Exhibitions Japan. Tel. +81 33 349 8519. Website: www.interphex.jp/en. supplier news Qualicaps acquires Genix WHITSETT, NC—Qualicaps acquired Genix Industria Farmaceutica, Brazil's sole manufacturer of hard cap- sules and a supplier to more than half the country's market. Qualicaps plans to use Genix as a springboard to ser- vice the Latin American pharmaceu- tical market, which IMS Health val- ues at $72 billion in 2014 and projects to grow at an average of 5 to 8 percent through 2019. Qualicaps FDA Clinical Trial Requirements Reg- ulations, Compliance, and GCP Con- ference. May 11-12 in Philadelphia, PA. Conducted by Society of Clinical Research Associates. Tel. 800 321 2211. Website: www.socra.org. European Association of Faculties of Pharmacy Annual Conference. May 12-14 in Paris, France. Conducted by the Université de Paris-Sud. Tel. +331 46 83 59 64. Website: www.eafpon- line.eu. Society for Clinical Trials Annual Meeting. May 15-18 in Montréal, Québec. Tel. 215 320 3878. Website: www.sctweb.org. FDA Drug Approval, Regulation, and Compliance. May 16-17 in New Brunswick, NJ. Conducted by the Cen- ter for Professional Advancement. Tel. 732 613 4500. Website: www.cfpa.com. The Manufacturing Process. May 11- 13 in Cleveland, OH. Conducted by Techceuticals. Tel. 216 658 8038. Web- site: www.techceuticals.com. Storage and Transportation of APIs and Finished Drug Products: Devel- oping Standards. May 23-24 in Rockville, MD. Conducted by U.S. Pharmacopeial Convention. Tel. 301 816 8130. Website: www.usp.org. Hands-on Course in Tablet Technol- ogy. May 22-27 at Oxford, MS. Con- ducted by the University of Mississippi School of Pharmacy. Tel. 662 915 7341. Website: www.tabcourse.com. Global Drug Delivery & Formulation Summit. May 23-25 in Berlin, Ger- many. Conducted by the World Trade Group. Tel. +44 20 7202 7690. Web- site: www.ddfevent.com. Drug Delivery: Fundamentals and Beyond. May 30-31 in Amsterdam, Netherlands. Conducted by the Center for Professional Advancement. Tel. 732 613 4500. Website: www.cfpa.com. June Quality Manufacturing Conference. June 6-8 in Bethesda, MD. Conducted by ISPE, FDA, and PQRI. Tel. 813 960 2105. Website: www.ispe.org. already operates sites in Japan, Spain, Romania, Canada, and the USA. Brazil is the world's eight-largest cap- sule market. Colorcon opens formulation services facility in Colombia HARLEYSVILLE, PA—Colorcon opened a technical service, labora- tory, and conference facility in Bogota, Colombia last month. The facility, certified to handle level II and IV APIs, includes a high-shear granulator, an instrumented tablet press, film coating equipment, and dissolution testing equipment. The company also plans to offer educa- tional programs about coating and formulation. Bilcare facility segregates pharma packaging from other operations WILMINGTON, DE—Bilcare Research, a blister packaging manu- facturer, segregated pharmaceutical packaging from operations at its Delaware facility. It's a response to customers seeking higher quality con- trol and the growing importance of pharmaceutical films to the company. Cirrus to launch GMP manufacturing at US site MORRISVILLE, NC—CDMO Cirrus Pharmaceuticals plans to dedi- cate a GMP manufacturing suite to making early-phase clinical trial mate- rials. The suite will be equipped to fill dry powders into the capsules used in inhalers and to manufacture solution- based metered-dose inhalers, oral solid dosage forms, and ointments. Velesco expands analytical testing at Michigan lab PLYMOUTH, MI—Velesco Pharma, a contract drug developer, added a GMP-compliant lab to its analytical facility here. The expan- sion increases its ability to test clients' stability samples by using HPLC, UPLC, titration, and other means, and to conduct dissolution, disintegration, and hardness tests. The lab will also test samples for cleaning validation studies, deter- mine in vitro equivalency, and char- acterize test articles.

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - TC0416